Single ascending dose study with healthy male volunteers and type II diabetic patients

Study identifier:D1920C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction after Single Ascending Oral Doses of AZD6714 in Healthy Male volunteers and Male Type II Diabetic Patients

Medical condition

Type 2 Diabetes

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD6714, Placebo

Sex

All

Actual Enrollment

26

Study type

Interventional

Age

20 Years - 40 Years

Date

Study Start Date: 01 Apr 2009
Primary Completion Date: 01 Sept 2009
Study Completion Date: 01 Sept 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria